S. Ramalingam

The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment

R. Huddart, L. Pickering, J. Larkin, 2022, Cardio-Oncology.

ESICM LIVES 2016: part two

A. M. Cavalheiro, H. S. King, M. M. Moraes, 2016, Intensive Care Medicine Experimental.

Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer

A. Ring, S. Stanway, A. Lyon, 2021, Breast Cancer Research and Treatment.

Clinical Utility and Prognostic Value of Coronary Computed Tomography Angiography in Patients With Cancer

Alexander R. Lyon, T. Murphy, S. Ramalingam, 2023, The American Journal of Cardiology.

Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditis

M. Nazir, S. Ramalingam, M. Andres, 2024, Cardio-oncology.

Cancer therapy related cardiac dysfunction as a result of Panitumumab

M. Nazir, S. Ramalingam, M. Andres, 2024, Cardio-oncology.